Navigation Links
Compound screening for drug development made simpler
Date:3/24/2010

les that can be incorporated into the software used to screen chemical libraries.

The filters were made publically available on 4 February through online publication in the Journal of Medicinal Chemistry.

High-throughput chemical screening has been used by large pharmaceutical companies for more than 20 years. In the past decade scientists at universities and research institutes and in small biotechnology companies have had increasing access to HTCS. "Many of them have spent vast amounts of time and money optimising and patenting molecules that were never going to amount to anything," Dr Baell said.

"We were in a position where we had all the data, we had the software, and we had the expertise to identify these molecules. Importantly, we also had the ability to publish our data.

"Pharmaceutical companies, which have used high-throughput chemical screening for many years, would know about many compounds that turn up as false positives. But they also operate in a competitive environment where publishing this data could compromise their competitive edge. For this particular situation, we didn't have such constraints."

Dr Baell said that within 48 hours of publishing the filters he was contacted by a number of pharmaceutical companies wishing to use them to assess their impact on their own high throughput screening libraries."


'/>"/>

Contact: Penny Fannin
fannin@wehi.edu.au
61-393-452-345
Walter and Eliza Hall Institute
Source:Eurekalert  

Page: 1 2

Related biology news :

1. URI pharmacy researcher finds beneficial compounds in pure maple syrup
2. Sanford-Burnham scientists identify natural compound that inhibits cancer cell migration
3. Scientists synthesize unique family of anti-cancer compounds
4. Scripps Research scientists find two compounds that lay the foundation for a new class of AIDS drug
5. Scripps Research scientists create new way to screen libraries of 10 million or more compounds
6. Natural compound blocks hepatitis C infection
7. Natural compounds in pomegranates may prevent growth of hormone-dependent breast cancer
8. New compounds may control deadly fungal infections
9. Compound found to safely counter deadly bird flu
10. Biogen Idecs oral compound BG-12 achieves development milestones in MS and RA
11. Anticancer compound found in American mayapple
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Compound screening for drug development made simpler
(Date:5/18/2015)... Fingerprint Cards (FPC) has received an order for ... from one if its module partners. Deliveries are planned to ... the sensors will be used by smartphone manufacturers in ... amount to 740 MSEK to date. In addition to previously ... number of smaller orders not separately communicated amounting to more ...
(Date:5/11/2015)... Curemark LLC, a privately held drug research ... Phase III double blind, randomized, placebo-controlled clinical trial to ... all children ages 3-8 with Autism. Previously, Curemark announced ... blinded clinical trial for CM-AT in children ages 3-8 ... enzyme chymotrypsin. This new trial will help determine whether ...
(Date:5/5/2015)... OXFORD, Conn. , May 5, 2015, NXT-ID, ... biometric authentication company focused on the growing mobile commerce market, ... the Company,s Chief Technology Officer, is presenting  at CARTES SECURE ... May 5-7, 2015. The three-day conference ... session David is speaking in is themed Global Fraud: ...
Breaking Biology News(10 mins):Fingerprint Cards Receives Touch Fingerprint Sensor Order of SEK 230 Million and Raises Revenue Guidance for 2015 2Curemark, LLC, Launches New Phase III Trial in Expanded Population of Children with Autism 2NXT-ID, Inc.'s CTO, David Tunnell, Presents at CARTES SECURE CONNEXIONS AMERICA 2015 Today in Washington DC. 2NXT-ID, Inc.'s CTO, David Tunnell, Presents at CARTES SECURE CONNEXIONS AMERICA 2015 Today in Washington DC. 3
... counts. Yet bruises, burns, and other physical conditions often ... drugs or solutions. , In response, a team of ... handheld device that uses Doppler ultrasound technology to find ... critical issues for vessel detection," says project leader Michael ...
... the risk of cardiovascular events -- a combined endpoint ... disease -- in both men and women, according to ... a Duke University Medical Center cardiologist. , However, the ... differed between the sexes. For men, aspirin lowered the ...
... regenerate damaged heart muscle in those who experience a first ... mesenchymal stem cells from healthy donor bone marrow that might ... of the stem cell product is that it is given ... require delivery to the site of the disease through catheterization ...
Cached Biology News:Researchers develop portable 'vein finder' for faster, more accurate injections 2Researchers develop portable 'vein finder' for faster, more accurate injections 3Aspirin reduces cardiovascular risks in men and women -- but differently 2Aspirin reduces cardiovascular risks in men and women -- but differently 3Stem cell study for patients with heart attack damage seeks to regenerate heart muscle 2Stem cell study for patients with heart attack damage seeks to regenerate heart muscle 3
(Date:5/20/2015)... The global genotyping market is expected ... forecast period of 2015 to 2020 to reach $17.0billion ... drug discovery and development process and to provide personalized ... to this,heavy investments by key manufacturers to offer advanced ... market growth. Browse 113 market data tables & 37 ...
(Date:5/20/2015)... May 20, 2015 Agricultural firm H.J. ... of its acquisition of Tiger-Sul. Since the purchase ... Alberta, Canada) in May 2005, H.J. Baker has leveraged ... it into a comprehensive portfolio of product offerings and ... H.J. Baker and the innovation of Tiger-Sul, transforming the ...
(Date:5/20/2015)... BRAINTREE, Mass. , May 20, 2015  Haemonetics ... Brian Concannon , President & CEO, will present at ... New York on June 1 st , ... public may access Mr. Concannon,s presentation live via webcast ... Haemonetics Haemonetics (NYSE: HAE ) is a ...
(Date:5/20/2015)... -- Resolution Bioscience announced today the successful results from their ... blood-based liquid biopsy for an ALK-gene fusion driver mutation ... common form of this cancer. Researchers or clinicians can ... therapies and direct them into clinical trials with a ... the CLIA authority in Washington State ...
Breaking Biology Technology:Genotyping Market Growing at 22.3% CAGR to 2020: Research Based on Technology, Applications, Opportunities, Challenges and Key Players. 2Genotyping Market Growing at 22.3% CAGR to 2020: Research Based on Technology, Applications, Opportunities, Challenges and Key Players. 3Genotyping Market Growing at 22.3% CAGR to 2020: Research Based on Technology, Applications, Opportunities, Challenges and Key Players. 4Genotyping Market Growing at 22.3% CAGR to 2020: Research Based on Technology, Applications, Opportunities, Challenges and Key Players. 5Agricultural Firm H.J. Baker & Bro., Inc., Celebrates 10 Years Since Acquisition Of Tiger-Sul 2Agricultural Firm H.J. Baker & Bro., Inc., Celebrates 10 Years Since Acquisition Of Tiger-Sul 3Resolution Bioscience Receives CLIA Certification for its Diagnostic Laboratory and Launches CLIA-Certified Liquid Biopsy for Lung Cancer 2
... tissue with the Big Blue transgenic,rodent mutation ... W. Glickman ,Centre for Environmental Health, University of Victoria, ... transgenic rodent mutation,assay,* which carries the E. ... it is easy to study mutations in male,and female ...
... vector system , Lisa Marsh ... system of eukaryotic expression ,vectors offers ... ,vectors can be exchanged without subcloning. Through ... cassettes are ,quickly and efficiently inserted into ...
... Novel pdual expression vector for high-level expression ... A. Padgett Joseph A. Sorge ,Stratagene , ... permits,high-level expression of heterologous genes in both eukaryotic ... enhancer region of the human,cytomegalovirus (CMV) immediate early ...
Cached Biology Technology:Tissue Specificity for Mutation Parallels Tissue Specificity for Cancer 2Tissue Specificity for Mutation Parallels Tissue Specificity for Cancer 3Tissue Specificity for Mutation Parallels Tissue Specificity for Cancer 4Tissue Specificity for Mutation Parallels Tissue Specificity for Cancer 5Tissue Specificity for Mutation Parallels Tissue Specificity for Cancer 6Tissue Specificity for Mutation Parallels Tissue Specificity for Cancer 7Mammalian Expression Vectors with Interchangeable Selectable Markers 2Mammalian Expression Vectors with Interchangeable Selectable Markers 3Mammalian Expression Vectors with Interchangeable Selectable Markers 4Mammalian and Bacterial Expression in One Vector 2Mammalian and Bacterial Expression in One Vector 3Mammalian and Bacterial Expression in One Vector 4Mammalian and Bacterial Expression in One Vector 5Mammalian and Bacterial Expression in One Vector 6
... 220-240 V, is a microfluidics-based system that ... including some data analysis, in 30 minutes. ... analysis (it does not include the vortex ... includes the electrophoresis station, priming station, software, ...
... Characteristics:, Antibody Binding: High, 400 ng ... volume) , Binding Interaction: Hydrophobic/Ionic , Performance ... (bottom): Flat , Maximum Well Volume: 360 ... tray ,Features, Special optically clear ...
... a dedicated system for SFC and SFE ... of HPLC instrumentation. JASCO has recently added ... of the system: ,- The PU-1580-CO2 delivery ... procedures using carbon dioxide as the mobile ...
... Fixed clamp trays and universal trays ... Magnetic drive Shaking speed: ... 25 mm amplitude Clamps ... 2000 ml, including Fernbach flasks ...
Biology Products: